Antidiabetic effects of chamomile flowers extract in obese mice through transcriptional stimulation of nutrient sensors of the Peroxisome Proliferator-Activated Receptor (PPAR) Family

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Weidner, Christopher ^a,b   Wowro, Sylvia J ^a   Rousseau, Morten ^a   Freiwald, Anja ^a   Kodelja, Vitam ^a   Abdel Aziz, Heba ^c   Kelber, Olaf ^c   Sauer, Sascha ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c Steigerwald Arzneimittelwerk GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CHAMOMILE; FATTY ACID; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BONE TURNOVER; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FLOWER; GENE EXPRESSION; GLUCOSE INTOLERANCE; HEMODILUTION; HEPATITIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIPID DIET; LIVER PROTECTION; MALE; MATRICARIA RECUTITA; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADIPOCYTES; ANIMALS; CELL LINE; CELLS, CULTURED; CHAMOMILE; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSLIPIDEMIAS; FATTY LIVER; FLOWERS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, OBESE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLANT EXTRACTS; PPAR GAMMA; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84893074878     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080335     Document Type: Article

References (50)

1. Smyth S, Heron A (2006) Diabetes and obesity: the twin epidemics. Nat Med 12: 75-80. doi:10.1038/nm0106-75. PubMed: 16397575. (Pubitemid 43050080)
2. WHO (2003) Obesity and Overweight - Fact sheet.
3. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846. doi:10.1038/nature05482. PubMed: 17167471. (Pubitemid 46024990)
4. Kliewer SA, Xu HE, Lambert MH, Willson TM (2001) Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 56: 239-263. doi:10.1210/rp.56.1.239. PubMed: 11237216.
5. Berger J, Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53: 409-435. doi:10.1146/annurev.med.53.082901.104018. PubMed: 11818483. (Pubitemid 34177889)
6. Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK et al. (2006) International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 58: 726-741. doi:10.1124/pr.58.4.5. PubMed: 17132851. (Pubitemid 44833742)
7. Lehrke M, Lazar MA (2005) The many faces of PPARgamma. Cell 123: 993-999. doi:10.1016/j.cell.2005.11.026. PubMed: 16360030.
8. Moreno M, Lombardi A, Silvestri E, Senese R, Cioffi F et al. (2010) PPARs: Nuclear Receptors Controlled by, and Controlling, Nutrient Handling through Nuclear and Cytosolic Signaling. PPAR Res 2010.
9. [Anon] (2010) Regulators restrict Avandia in the US and suspend it in the EU. Nat Rev Drug Discov 9: 828-828. doi:10.1038/nrd3317.
10. Rosen CJ (2010) Revisiting the rosiglitazone story - lessons learned. N Engl J Med 363: 803-806. doi:10.1056/NEJMp1008233. PubMed: 20660395.
11. Argmann CA, Cock TA, Auwerx J (2005) Peroxisome proliferator-activated receptor gamma: the more the merrier? Eur J Clin Invest 35: 80-92; discussion: 10.1111/j.1365-2362.2005.01456.x. PubMed: 15667578.
12. Cock TA, Houten SM, Auwerx J (2004) Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm. EMBO Rep 5: 142-147. doi:10.1038/sj.embor.7400082. PubMed: 14755307. (Pubitemid 38401192)
13. Gronemeyer H, Gustafsson JA, Laudet V (2004) Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3: 950-964. doi:10.1038/nrd1551. PubMed: 15520817. (Pubitemid 39534319)
14. Pourcet B, Fruchart JC, Staels B, Glineur C (2006) Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis. Expert Opin Emerg Drugs 11: 379-401. doi:10.1517/14728214.11.3.379. PubMed: 16939380. (Pubitemid 44386365)
15. Li JW, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325: 161-165. doi:10.1126/science.1168243. PubMed: 19589993.
16. Ganesan A (2004) Natural products as a hunting ground for combinatorial chemistry. Curr Opin Biotechnol 15: 584-590. doi:10.1016/j.copbio.2004.09.002. PubMed: 15560986.
17. Müller M, Kersten S (2003) Nutrigenomics: goals and strategies. Nat Rev Genet 4: 315-322. doi:10.1038/nrg1047. PubMed: 12671662. (Pubitemid 36389536)
18. Kroll U, Cordes C (2006) Pharmaceutical prerequisites for a multi-target therapy. Phytomedicine 13 Suppl 5: 12-19. doi:10.1016/j.phymed.2006.03.016. PubMed: 16857355. (Pubitemid 44809866)
19. Wegener T, Wagner H (2006) The active components and the pharmacological multi-target principle of STW 5 (Iberogast). Phytomedicine 13 Suppl 5: 20-35. doi:10.1016/j.phymed.2006.07.001. PubMed: 16926095. (Pubitemid 44809868)
20. Weidner C, de Groot JC, Prasad A, Freiwald A, Quedenau C et al. (2012) Amorfrutins are potent antidiabetic dietary natural products. Proc Natl Acad Sci U S A 109: 7257-7262. doi:10.1073/pnas.1116971109. PubMed: 22509006.
21. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. doi:10.1006/meth.2001.1262. PubMed: 11846609. (Pubitemid 34164012)
22. Spiegelman BM (1998) PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47: 507-514. doi:10.2337/diabetes.47.4.507. PubMed: 9568680.
23. Spiegelman BM, Frank M, Green H (1983) Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J Biol Chem 258: 10083-10089. PubMed: 6411703.
24. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9: 213-219. doi:10.1038/nm820. PubMed: 12524534. (Pubitemid 36227724)
25. Portincasa P, Grattagliano I, Palmieri VO, Palasciano G (2006) Current pharmacological treatment of nonalcoholic fatty liver. Curr Med Chem 13: 2889-2900. doi:10.2174/092986706778521878. PubMed: 17073635. (Pubitemid 44509714)
26. Heikkinen S, Argmann CA, Champy MF, Auwerx J (2007) Evaluation of glucose homeostasis. Curr Protoc Mol Biol Chapter 29: Unit 29B.3: Unit 29B 23. PubMed: 18265403
27. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444: 860-867. doi:10.1038/nature05485. PubMed: 17167474.
28. Meierhofer D, Weidner C, Hartmann L, Mayr JA, Han CT et al. (2013) Protein sets define disease States and predict in vivo effects of drug treatment. Mol Cell Proteomics 12: 1965-1979. doi:10.1074/mcp.M112.025031. PubMed: 23579186.
29. Evans RM, Barish GD, Wang YX (2004) PPARs and the complex journey to obesity. Nat Med 10: 355-361. doi:10.1038/nm1025. PubMed: 15057233. (Pubitemid 38508511)
30. Singh O, Khanam Z, Misra N, Srivastava MK (2011) Chamomile (Matricaria chamomilla. p. L.): An overview. Pharmacogn Rev 5: 82-95
31. Weidner C, Wowro SJ, Freiwald A, Kawamoto K, Witzke A et al. (2013) Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPARgamma) agonist with potent glucose-lowering properties. Diabetologia.
32. Heinle H, Hagelauer D, Pascht U, Kelber O, Weiser D (2006) Intestinal spasmolytic effects of STW 5 (Iberogast) and its components. Phytomedicine 13 Suppl 5: 75-79. doi:10.1016/j.phymed.2006.03.013. PubMed: 16709451. (Pubitemid 44816467)
33. Hohenester B, Rühl A, Kelber O, Schemann M (2004) The herbal preparation STW5 (lberogast) has potent and region-specific effects on gastric motility. Neurogastroent Motil 16: 765-773. doi:10.1111/j.1365-2982.2004.00548. x. PubMed: 15601427. (Pubitemid 40022784)
34. Cemek M, Kaga S, Simsek N, Buyukokuroglu ME, Konuk M (2008) Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats. J Nat Med 62: 284-293.
35. Kato A, Minoshima Y, Yamamoto J, Adachi I, Watson AA et al. (2008) Protective effects of dietary chamomile tea on diabetic complications. J Agric Food Chem 56: 8206-8211. doi:10.1021/jf8014365. PubMed: 18681440.
36. Eddouks M, Lemhadri A, Zeggwagh NA, Michel JB (2005) Potent hypoglycaemic activity of the aqueous extract of Chamaemelum nobile in normal and streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 67: 189-195. doi:10.1016/j.diabres.2004.07.015. PubMed: 15713350. (Pubitemid 40254307)
37. Ak Gupta, Misra N (2006) Hepatoprotective Activity of Aqueous Ethanolic Extract of Chamomile capitula in Paracetamol Intoxicated Albino Rats. Am J Pharmacol Toxicol 1: 17-20. doi:10.3844/ajptsp.2006.17.20.
38. Lalloyer F, Staels B (2010) Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 30: 894-899. doi:10.1161/ATVBAHA.108.179689. PubMed: 20393155.
39. Doshi LS, Brahma MK, Bahirat UA, Dixit AV, Nemmani KV (2010) Discovery and development of selective PPAR gamma modulators as safe and effective antidiabetic agents. Expert Opin Investig Drugs 19: 489-512. doi:10.1517/13543781003640169. PubMed: 20367191.
40. Cho N, Momose Y (2008) Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress. Curr Top Med Chem 8: 1483-1507. doi:10.2174/156802608786413474. PubMed: 19075761.
41. Harbourne N, Jacquier JC, O'Riordan D (2009) Optimisation of the extraction and processing conditions of chamomile (Matricaria chamomilla L.) for incorporation into a beverage. Food Chem 115: 15-19. doi:10.1016/j.foodchem. 2008.11.044.
42. Medjakovic S, Mueller M, Jungbauer A (2010) Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR. Nutrients 2: 241-279. doi:10.3390/nu2030241. PubMed: 22254019.
43. Mueller M, Lukas B, Novak J, Simoncini T, Genazzani AR et al. (2008) Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists. J Agric Food Chem 56: 11621-11630. doi:10.1021/jf802298w. PubMed: 19053389.
44. Liang YC, Tsai SH, Tsai DC, Lin-Shiau SY, Lin JK (2001) Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett 496: 12-18. doi:10.1016/S0014-5793(01)02393-6. PubMed: 11343698.
45. Wilkinson AS, Monteith GR, Shaw PN, Lin CN, Gidley MJ et al. (2008) Effects of the mango components mangiferin and quercetin and the putative mangiferin metabolite norathyriol on the transactivation of peroxisome proliferator-activated receptor isoforms. J Agric Food Chem 56: 3037-3042. doi:10.1021/jf800046n. PubMed: 18393431. (Pubitemid 351746026)
46. Puhl AC, Bernardes A, Silveira RL, Yuan J, Campos JL et al. (2012) Mode of peroxisome proliferator-activated receptor gamma activation by luteolin. Mol Pharmacol 81: 788-799. doi:10.1124/mol.111.076216. PubMed: 22391103.
47. Christensen KB, Petersen RK, Kristiansen K, Christensen LP (2010) Identification of bioactive compounds from flowers of black elder (Sambucus nigra L.) that activate the human peroxisome proliferator-activated receptor (PPAR) gamma. Phytother Res 24 Suppl 2: S129-S132. doi:10.1002/ptr.2889. PubMed: 20222152.
48. McCarty MF (2005) Nutraceutical resources for diabetes prevention - an update. Med Hypotheses 64: 151-158. doi:10.1016/j.mehy.2004.03.036. PubMed: 15533633.
49. Chuang CC, McIntosh MK (2011) Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases. Annu Rev Nutr 31: 155-176. doi:10.1146/annurev-nutr-072610-145149. PubMed: 21548775.
50. Yang X, Downes M, Yu RT, Bookout AL, He W et al. (2006) Nuclear receptor expression links the circadian clock to metabolism. Cell 126: 801-810. doi:10.1016/j.cell.2006.06.050. PubMed: 16923398. (Pubitemid 44233631)